Metabolomics and network pharmacology reveal partial insights into the hypolipidemic mechanisms of ferulic acid in a dyslipidemia mouse model

• Main Authors: Zhihao Zeng (Author), Guanlin Xiao (Author), Yanchang Liu (Author), Minshan Wu (Author), Xingqin Wei (Author), Canhui Xie (Author), Guangying Wu (Author), Dezheng Jia (Author), Yangxue Li (Author), Sumei Li (Author), Xiaoli Bi (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

IntroductionHyperlipidemia is a condition characterized by abnormal levels of lipids and lipoproteins in the plasma, posing significant health risks. Ferulic acid (FA) is an organic acid with therapeutic properties for diabetes and hyperlipidemia.MethodsTo explore biomarkers for FA treatment of hype...